# ClearPoint Neuro, Inc. (CLPT)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CLPT/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 37.86M | $ -26.15M | $ -25.03M | $ 58.23M | $ 28.02M |
| 2024 | $ 32.99M | $ -19.88M | $ -9.70M | $ 3.57M | $ 25.39M |
| 2023 | $ 25.90M | $ -23.88M | $ -15.79M | $ 13.94M | $ 21.17M |
| 2022 | $ 22.96M | $ -18.36M | $ -18.47M | $ 11.99M | $ 36.89M |
| 2021 | $ 19.37M | $ -17.13M | $ -15.68M | $ 12.28M | $ 48.79M |
| 2020 | $ 16.34M | $ -8.64M | $ -10.56M | $ 24.12M | $ 2.38M |
| 2019 | $ 14.48M | $ -7.15M | $ -3.69M | $ 2.46M | $ 4.59M |
| 2018 | $ 9.71M | $ -8.14M | $ -6.20M | $ 3.48M | $ 1.51M |
| 2017 | $ 9.94M | $ -9.66M | $ -7.91M | $ 4.92M | $ 5.83M |
| 2016 | $ 7.91M | $ -11.10M | $ -8.15M | $ 4.49M | $ -756.1K |
| 2015 | $ 6.45M | $ -11.86M | $ -12.24M | $ 8.11M | $ -1.98M |
| 2014 | $ 5.09M | $ -6.39M | $ -10.31M | $ 7.69M | $ -100.3K |
| 2013 | $ 5.59M | $ -10.26M | $ -11.31M | $ 8.42M | $ -6.83M |
| 2012 | $ 7.30M | $ -8.24M | $ -10.92M | $ 6.53M | $ -5.74M |
| 2011 | $ 4.47M | $ -8.90M | $ -4.09M | $ 7.46M | $ -21.84M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 2.08 |
| Liabilities / Eq | 2.49 |
| Current Ratio | 5.91 |

## Other views

- [Metrics](https://sponda.capital/en/CLPT.md)
- [Charts](https://sponda.capital/en/CLPT/charts.md)
- [Compare](https://sponda.capital/en/CLPT/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.